Medical Treatment of Benign Prostatic Hyperplasia: 5α-Reductase Inhibitors and α-Adrenergic Antagonists

This publication has 39 references indexed in Scilit:

• The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasia
  The Prostate, 1993
• Finasteride in the Treatment of Benign Prostatic Hyperplasia. A Urodynamic Evaluation
  British Journal of Urology, 1992
• Alfuzosin for treatment of benign prostatic hypertrophy
  The Lancet, 1991
• The clinical development of a 5α-reductase inhibitor, finasteride
  The Journal of Steroid Biochemistry and Molecular Biology, 1990
• A Multicenter, Double-Blind, Placebo-Controlled Trial of the Efficacy of Prazosin in the Treatment of Dysuria Associated with Benign Prostatic Hypertrophy
  Urologia Internationalis, 1990
• A Twelve-Week Placebo-Controlled Study of Prazosin in the Treatment of Prostatic Obstruction
  Urologia Internationalis, 1990
• Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1989
• Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled Study
  British Journal of Urology, 1987
• A Double‐blind Controlled Trial of a New α‐1 Blocking Drug in the Treatment of Bladder Outflow Obstruction
  British Journal of Urology, 1985
• Effect of a new 5α-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate
  The Prostate, 1982